NEOS
Neos Therapeutics, Inc
NEOS
NEOS
Delisted
NEOS was delisted on the 19th of March, 2021.
63 hedge funds and large institutions have $71.2M invested in Neos Therapeutics, Inc in 2019 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 26 increasing their positions, 17 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
63
Holders Change
–
Holders Change %
0%
% of All Funds
1.37%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
26
Reduced
17
Closed
6
Calls
$76K
Puts
$91K
Net Calls
-$15K
Net Calls Change
+$99K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
$5.34M |
| 2 |
Goldman Sachs
New York
|
$3.22M |
| 3 |
DM
Deerfield Management
New York
|
$4.7M |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
$11.8M |
| 5 |
Millennium Management
New York
|
$845K |
Top Sellers
| 1 |
BC
Broadfin Capital
New York
|
$4.21M |
| 2 |
JGC
J. Goldman & Co
New York
|
$313K |
| 3 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
$0 |
| 4 |
PCM
Proxima Capital Management
New York
|
$538K |
| 5 |
BlackRock
New York
|
$6.97M |
